EDP Sciences logo
Search
Menu
All issues Reprod. Nutr. Dev., 36 4 (1996) 399-406 Article references

Articles citing this article

The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).

Cited article:

Influence of sibutramine in addition to diet and exercise on the relationship between weight loss and blood glucose changes

Sadaf Kamil, Nicholas Finer, William Philip T James, et al.
European Heart Journal - Cardiovascular Pharmacotherapy pvw029 (2016)
https://doi.org/10.1093/ehjcvp/pvw029

Effects of celiac superior mesenteric ganglionectomy on glucose homeostasis and hormonal changes during oral glucose tolerance testing in rats

Atsushi Kumakura, Junpei Shikuma, Norikazu Ogihara, et al.
Endocrine Journal (2012)
https://doi.org/10.1507/endocrj.EJ11-0326

A free-choice high-fat high-sugar diet induces glucose intolerance and insulin unresponsiveness to a glucose load not explained by obesity

S E la Fleur, M C M Luijendijk, A J van Rozen, A Kalsbeek and R A H Adan
International Journal of Obesity 35 (4) 595 (2011)
https://doi.org/10.1038/ijo.2010.164

Sovremennye vozmozhnosti farmakoterapii sakharnogo diabeta 2 tipa pri pomoshchi analogov glyukagonopodobnogo peptida-1 (GPP-1)

Marina Vladimirovna Shestakova and Olga Konstantinovna Vikulova
Diabetes mellitus 10 (1) 9 (2007)
https://doi.org/10.14341/2072-0351-5908

Exenatide: a GLP-1 receptor agonist as novel therapy for Type 2 diabetes mellitus

Mariele Briones and Mandeep Bajaj
Expert Opinion on Pharmacotherapy 7 (8) 1055 (2006)
https://doi.org/10.1517/14656566.7.8.1055

Neuroendocrine Correlates of Sleep/Wakefulness

Marieke Ruiter, Ruud M. Buijs and Andries Kalsbeek
Neuroendocrine Correlates of Sleep/Wakefulness 87 (2006)
https://doi.org/10.1007/0-387-23692-9_5

Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus

Orville G. Kolterman, Dennis D. Kim, Larry Shen, et al.
American Journal of Health-System Pharmacy 62 (2) 173 (2005)
https://doi.org/10.1093/ajhp/62.2.173

Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes

Loretta L. Nielsen, Andrew A. Young and David G. Parkes
Regulatory Peptides 117 (2) 77 (2004)
https://doi.org/10.1016/j.regpep.2003.10.028

Unlike mice, dogs exhibit effective glucoregulation during low-dose portal and peripheral glucose infusion

Mary Courtney Moore, Sylvain Cardin, Dale S. Edgerton, et al.
American Journal of Physiology-Endocrinology and Metabolism 286 (2) E226 (2004)
https://doi.org/10.1152/ajpendo.00343.2003

Impaired Glucose Homeostasis in Mice Lacking the α1b-Adrenergic Receptor Subtype

Rémy Burcelin, Marc Uldry, Marc Foretz, Christophe Perrin, Anabela Dacosta, Monique Nenniger-Tosato, Josiane Seydoux, Susanna Cotecchia and Bernard Thorens
Journal of Biological Chemistry 279 (2) 1108 (2004)
https://doi.org/10.1074/jbc.M307788200

Synthetic Exendin-4 (Exenatide) Significantly Reduces Postprandial and Fasting Plasma Glucose in Subjects with Type 2 Diabetes

Orville G. Kolterman, John B. Buse, Mark S. Fineman, et al.
The Journal of Clinical Endocrinology & Metabolism 88 (7) 3082 (2003)
https://doi.org/10.1210/jc.2002-021545